Body mass index, diabetes, and mortality in french women: Explaining away a "paradox"

Epidemiology

Volumn 25, Issue 1, 2014, Pages 10-14

  Lajous, Martin ^a,b,c   Bijon, Anne ^c,d   Fagherazzi, Guy ^c,d   Boutron Ruault, Marie Christine ^c,d   Balkau, Beverley ^c,d   Clavel Chapelon, Françoise ^c,d   Hernán, Miguel A ^a,e  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c INSERM   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; DIABETES MELLITUS; FEMALE; FOLLOW UP; FRANCE; HAZARD RATIO; HUMAN; MORTALITY; PRIORITY JOURNAL;

ADULT; AGED; BODY MASS INDEX; COMORBIDITY; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; FEMALE; FRANCE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; OBESITY; OVERWEIGHT; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SELECTION BIAS;

EID: 84890123720     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000031     Document Type: Article

References (25)

1. Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363:2211-2219
2. Carnethon MR, De Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308: 581-590
3. O reopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: A metaanalysis. Am Heart J. 2008;156:13-22
4. O reopoulos A, Padwal R, Norris CM, Mullen JC, Pretorius V, Kalantar-Zadeh K. Effect of obesity on short-And long-Term mortality postcoronary revascularization: A meta-Analysis. Obesity (Silver Spring). 2008;16:442-450
5. Anker SD, von Haehling S. The obesity paradox in heart failure: Accepting reality and making rational decisions. Clin Pharmacol Ther. 2011;90:188-190
6. Hernán MA, Hernández-Díaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15:615-625
7. F erreira I, Stehouwer CD. Obesity paradox or inappropriate study designs? Time for life-course epidemiology. J Hypertens. 2012;30: 2271-2275
8. Dahabreh IJ, Kent DM. Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA. 2011;305:822-823
9. Banack HR, Kaufman JS. The obesity paradox explained. Epidemiology. 2013;24:461-462
10. Lainscak M, von Haehling S, Doehner W, Anker SD. The obesity paradox in chronic disease: Facts and numbers. J Cachexia Sarcopenia Muscle. 2012;3:1-4
11. R iboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): Study populations and data collection. Public Health Nutr. 2002;5(6B):1113-1124
12. T seng CH. Obesity paradox: Differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus. Atherosclerosis. 2013;226:186-192
13. Kastorini CM, Panagiotakos DB. The obesity paradox: Methodological considerations based on epidemiological and clinical evidence-new insights. Maturitas. 2012;72:220-224
14. Wacholder S. Precursors in cancer epidemiology: Aligning definition and function. Cancer Epidemiol Biomarkers Prev. 2013;22:521-527
15. P erry JR, Voight BF, Yengo L, et al.; MAGIC; DIAGRAM Consortium; GIANT Consortium. Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. PLoS Genet. 2012;8:e1002741
16. Hernández-Díaz S, Schisterman EF, Hernán MA. The birth weight paradox uncovered? Am J Epidemiol. 2006;164:1115-1120
17. Hernán MA, Clayton D, Keiding N. The Simpson's paradox unraveled. Int J Epidemiol. 2011;40:780-785
18. Snoep JD, Morabia A, Hernandez-Diaz S, Hernan MA, Vandenbroucke JP. A structural approach to Berkson's fallacy. Int J Epidemiol. 2013 (in press
19. Hernán MA, Alonso A, Logan R, et al. Observational studies analyzed like randomized experiments: An application to postmenopausal hormone therapy and coronary heart disease. Epidemiology. 2008;19:766-779
20. Danaei G, Tavakkoli M, Hernán MA. Bias in observational studies of prevalent users: Lessons for comparative effectiveness research from a meta-Analysis of statins. Am J Epidemiol. 2012;175:250-262
21. Hernán MA. The hazards of hazard ratios. Epidemiology. 2010;21:13-15
22. Hernán MA, Taubman SL. Does obesity shorten life? The importance of well-Defined interventions to answer causal questions. Int J Obes (Lond). 2008;32(suppl 3):S8-S14
23. Hernán MA, VanderWeele TJ. Compound treatments and transportability of causal inference. Epidemiology. 2011;22:368-377
24. Cole SR, Hernán MA. Fallibility in estimating direct effects. Int J Epidemiol. 2002;31:163-165
25. R obins JM. A new approach to causal inference in mortality studies with sustained exposure periods-Application to control of the healthy worker survivor effect. Mathematical Modelling 1986;7:1393-1512